Joerg Schwarz
Overview
Explore the profile of Joerg Schwarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woelber L, Grimm D, Vettorazzi E, Wisotzki C, Trillsch F, Jaenicke F, et al.
Ann Surg Oncol
. 2012 Nov;
20(5):1701-6.
PMID: 23132121
Background: To reduce morbidity of radical groin dissection, the sentinel-node (SLN) procedure was implemented for the treatment of vulvar cancer. It has been proven to be a safe alternative in...
2.
Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R, et al.
Arch Gynecol Obstet
. 2012 Aug;
286(6):1549-54.
PMID: 22865036
Purpose: Conization for suspected high grade cervical intraepithelial neoplasia (CIN) is often performed based on abnormal cytology only. Loop electrosurgical excision procedure (LEEP) is a very common technique in this...
3.
Woelber L, Choschzick M, Eulenburg C, Hager M, Jaenicke F, Gieseking F, et al.
Ann Surg Oncol
. 2011 May;
18(13):3811-8.
PMID: 21594705
Background: A tumor-free resection margin of at least 8 mm is considered state of the art in vulvar cancer. This standard is based on small and heterogeneous patient cohorts, and...
4.
Mury D, Woelber L, Jung S, Eulenburg C, Choschzick M, Witzel I, et al.
J Cancer Res Clin Oncol
. 2011 Feb;
137(7):1131-7.
PMID: 21344262
Introduction: Despite radical surgery and chemotherapy, most patients with ovarian cancer develop recurrence and die due to progressive disease. To stratify patients for optimal therapy, prognostic and predictive factors are...
5.
Kock L, Mahner S, Choschzick M, Eulenburg C, Milde-Langosch K, Schwarz J, et al.
Int J Gynecol Cancer
. 2011 Feb;
21(1):141-8.
PMID: 21330838
Introduction: Therapeutic options in advanced or recurrent vulvar cancer are limited. The identification of new prognostic factors and markers for therapy stratification is therefore highly desirable. Carbonic anhydrase IX (CAIX)...
6.
Woelber L, Kress K, Kersten J, Choschzick M, Kilic E, Herwig U, et al.
BMC Cancer
. 2011 Jan;
11:12.
PMID: 21223596
Background: Carbonic anhydrase IX (CAIX) is a membranous expressed metalloenzyme involved in pH homeostasis and cell adhesion. The protein is overexpressed in a variety of tumors and potentially associated with...
7.
Mahner S, Woelber L, Eulenburg C, Schwarz J, Carney W, Jaenicke F, et al.
BMC Cancer
. 2010 Apr;
10:139.
PMID: 20388222
Background: Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth factor (VEGF) has recently been implicated as a therapeutic target in ovarian cancer. The tissue inhibitor...
8.
Woelber L, Mueller V, Eulenburg C, Schwarz J, Carney W, Jaenicke F, et al.
Gynecol Oncol
. 2010 Jan;
117(2):183-8.
PMID: 20051287
Objective: Carbonic anhydrase IX (CAIX) is primarily involved in maintaining the extracellular pH. It is overexpressed in a variety of tumors including ovarian cancer. To evaluate the potential prognostic and...
9.
Mahner S, Woelber L, Jung S, Zu Eulenburg C, Ihnen M, Schwarz J, et al.
Anticancer Res
. 2009 Jul;
29(7):2817-21.
PMID: 19596967
Background: Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrence and die due to progressive disease. Routine measurement of the tumor marker CA-125 is...
10.
Woelber L, Mahner S, Voelker K, Zu Eulenburg C, Gieseking F, Choschzick M, et al.
Anticancer Res
. 2009 Apr;
29(2):545-52.
PMID: 19331201
Background: Vulvar cancer is a rare disease and knowledge on prognostic factors is therefore limited and inconsistent. The aim of this study was to determine prognostic variables for recurrence and...